Search research articles
Contact Us
Filters
Showing results (81-90 of 299) with videos related to
Page
of 30
Sort By:
Transplantation Proceedings
|
April 1, 1988
Cells invading tumors: strategies for the identification and expansion of tumor reactive lymphocytes
M T Lotze, W G Ross, S Tomita, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy
|
August 1, 1993
Interleukin-12 promotes the proliferation and cytolytic maturation of immune effectors: implications for the immunotherapy of cancer
H J Zeh, S Hurd, W J Storkus, et al.
European Journal of Immunology
|
November 22, 1997
Genetically modified bone marrow-derived dendritic cells expressing tumor-associated viral or "self" antigens induce antitumor immunity in vivo
T Tüting, A B DeLeo, M T Lotze, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy
|
May 1, 1995
In situ interleukin-4 gene expression in cancer patients treated with genetically modified tumor vaccine
Y Suminami, E M Elder, M T Lotze, et al.
Journal of Biological Response Modifiers
|
April 1, 1990
Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing
E A Wiebke, M C Custer, S A Rosenberg, et al.
Annals of Surgical Oncology
|
August 24, 1999
Recent advances in melanoma staging and therapy
K M McMasters, V K Sondak, M T Lotze, et al.
Cancer Research
|
August 27, 1999
Induction of systemic and therapeutic antitumor immunity using intratumoral injection of dendritic cells genetically modified to express interleukin 12
Y Nishioka, M Hirao, P D Robbins, et al.
Journal of Surgical Oncology
|
November 10, 1998
Distant skin and soft tissue metastases from sarcomas
U N Rao, S H Hanan, M T Lotze, et al.
Immunology Today
|
December 1, 1995
TCR usage in CTLs recognizing melanoma/melanocyte antigens
M J Maeurer, D M Martin, W J Storkus, et al.
Immunological Investigations
|
June 15, 2000
Dendritic cells promote T-cell survival or death depending upon their maturation state and presentation of antigen
R B Mailliard, R M Dallal, Y I Son, et al.
Page
of 30
Search research articles
Search
Showing results (81-90 of 299) with videos related to
Sort By:
Page
of 30
Transplantation Proceedings
|
April 1, 1988
Cells invading tumors: strategies for the identification and expansion of tumor reactive lymphocytes
M T Lotze, W G Ross, S Tomita, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy
|
August 1, 1993
Interleukin-12 promotes the proliferation and cytolytic maturation of immune effectors: implications for the immunotherapy of cancer
H J Zeh, S Hurd, W J Storkus, et al.
European Journal of Immunology
|
November 22, 1997
Genetically modified bone marrow-derived dendritic cells expressing tumor-associated viral or "self" antigens induce antitumor immunity in vivo
T Tüting, A B DeLeo, M T Lotze, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy
|
May 1, 1995
In situ interleukin-4 gene expression in cancer patients treated with genetically modified tumor vaccine
Y Suminami, E M Elder, M T Lotze, et al.
Journal of Biological Response Modifiers
|
April 1, 1990
Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing
E A Wiebke, M C Custer, S A Rosenberg, et al.
Annals of Surgical Oncology
|
August 24, 1999
Recent advances in melanoma staging and therapy
K M McMasters, V K Sondak, M T Lotze, et al.
Cancer Research
|
August 27, 1999
Induction of systemic and therapeutic antitumor immunity using intratumoral injection of dendritic cells genetically modified to express interleukin 12
Y Nishioka, M Hirao, P D Robbins, et al.
Journal of Surgical Oncology
|
November 10, 1998
Distant skin and soft tissue metastases from sarcomas
U N Rao, S H Hanan, M T Lotze, et al.
Immunology Today
|
December 1, 1995
TCR usage in CTLs recognizing melanoma/melanocyte antigens
M J Maeurer, D M Martin, W J Storkus, et al.
Immunological Investigations
|
June 15, 2000
Dendritic cells promote T-cell survival or death depending upon their maturation state and presentation of antigen
R B Mailliard, R M Dallal, Y I Son, et al.
Page
of 30